Researchers mapping three-dimensional DNA folding in rare human tonsil immune cells have linked Crohn’s disease genetic risk variants to more than 100 target genes, revealing an unexpected connection to neurodegenerative disease pathways through the gene CLN3. The findings were published on August 4, 2026, in Nature Genetics.
Our genetic material is rarely read as a straight, linear code. Bundled tightly inside the nucleus of a cell, two meters of DNA fold into a complex three-dimensional structure that brings distant regions into physical contact. Promoters initiate gene transcription, while enhancers act as molecular switches boosting gene activity from thousands or even millions of DNA bases away. When the genome folds, these enhancers loop around to touch their target genes. Understanding this physical architecture is essential for interpreting genome-wide association studies, which frequently find disease-associated genetic variants sitting in non-coding regulatory spaces rather than inside protein-coding genes.
Mini-Capture Hi-C Breakthrough in Rare ILC3 Immune Cells
Until recently, mapping these long-range physical contacts across the genome presented a massive technological hurdle. Standard chromosome-conformation methods such as Capture Hi-C required millions of cells as input, restricting high-resolution 3D genomics to abundant or mixed cell populations like circulating blood. That left rare, specialized cell types largely out of reach. To pierce this barrier, researchers developed an optimized, low-input technology known as mini-Capture Hi-C. This advancement made it possible to profile 3D DNA folding using dramatically fewer cells from human tonsil tissue.
The international research team applied the method to type 3 innate lymphoid cells, or ILC3s. These tissue-resident immune cells help protect barrier surfaces in the gut and regulate local inflammation. Although ILC3s are known contributors to inflammatory bowel disease, their scarcity and inability to replicate well outside the body made them notoriously difficult to study at the level of chromatin organization. By bringing high-resolution 3D mapping to ILC3s, the scientists could finally connect disease-linked mutations in regulatory DNA directly to the genes they control.
Prioritizing Crohn’s Disease Risk Genes and Identifying CLN3
To turn these spatial interaction maps into biological insights, the investigators combined their 3D chromatin data with results from large-scale genome-wide association studies. Using a specialized Bayesian multi-variant analysis framework, they connected Crohn’s disease risk variants to the specific promoters those regulatory regions touch in ILC3s. The analysis prioritized more than 100 candidate genes, roughly half of which were previously unknown in the context of inflammatory bowel disease.
Among the most striking discoveries was the implication of CLN3, a gene best known for causing Batten disease, a rare neurodegenerative disorder. Because CLN3 is classically studied within the nervous system, its active role in gut immune cells caught the research team by surprise.
Follow-up functional experiments in mouse cell models shed light on how the gene operates in immune contexts. While the study does not establish CLN3 as a direct causal driver of Crohn’s disease in humans, the findings point to an unexpected intersection between neurodevelopmental pathways and immune regulation.
Next Steps and Therapeutic Horizons
The research illustrates why accounting for cell type is crucial when interpreting human genetic risk. An inherited regulatory variant is identical in every cell, but the way DNA folds dictates which gene it actually touches in a specific tissue. A variant might regulate one gene in an intestinal immune cell and an entirely different gene—or none at all—in circulating blood.
With a validated catalog of ILC3-linked risk genes now established, the team aims to clarify the precise mechanisms by which genes like CLN3 modulate immune cell function. Investigators also plan to adapt the low-input 3D mapping strategy to probe other rare, disease-relevant cell types that have remained hidden behind technical barriers.
Keep reading
